Considering that accumulation of amyloid and tau proteins in the brain are involved in the pathogenesis of neurodegenerative diseases, the potential of treating hypertension by methods that focus on nasal turbinate obstruction and/or increasing cerebrospinal fluid lymphatic flow may also offer a therapeutic benefit for neurodegenerative pathologies in addition to its potential to treat hypertension. This evidence concerns the gene MAPT and hypertensive disorder.